TrialAntiviral therapy2016

Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results.

Michelle A Floris-Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.